Schein "Patent Review" Revenues Reach $78 Mil.; Engleberg Deal Ending
Executive Summary
Schein's "patent review" revenues have grown to more than 15% of the company's total sales, the generic manufacturer and distributor disclosed in its registration statement for an initial public offering.